Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry

  1. Bjartell, A.
  2. Lumen, N.
  3. Maroto, P.
  4. Paiss, T.
  5. Gomez-Veiga, F.
  6. Birtle, A.
  7. Kramer, G.
  8. Kalinka, E.
  9. Spaëth, D.
  10. Feyerabend, S.
  11. Matveev, V.
  12. Lefresne, F.
  13. Lukac, M.
  14. Wapenaar, R.
  15. Costa, L.
  16. Chowdhury, S.
Revista:
Targeted Oncology

ISSN: 1776-260X 1776-2596

Ano de publicación: 2021

Volume: 16

Número: 3

Páxinas: 357-367

Tipo: Artigo

DOI: 10.1007/S11523-021-00807-4 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable